Immediate Impact
3 by Nobel laureates 17 from Science/Nature 58 standout
Citing Papers
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Works of Cathy Chang being referenced
Abstract 833: Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC
2018
A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors.
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Cathy Chang | 63 | 167 | 61 | 209 | 98 | 18 | 369 | |
| Wilson Caparrós‐Wanderley | 32 | 188 | 33 | 189 | 76 | 15 | 384 | |
| S. Grell | 48 | 199 | 23 | 102 | 53 | 14 | 394 | |
| Amy Ransier | 22 | 131 | 47 | 125 | 85 | 13 | 305 | |
| A. de Reus | 35 | 144 | 38 | 151 | 55 | 14 | 343 | |
| W E Rawls | 81 | 147 | 41 | 292 | 55 | 13 | 394 | |
| Joan C. Enterline | 25 | 128 | 50 | 88 | 119 | 16 | 327 | |
| Vanessa M. Cowton | 59 | 94 | 17 | 192 | 152 | 18 | 379 | |
| Juan Carlos Aldave Becerra | 55 | 196 | 28 | 80 | 84 | 19 | 372 | |
| J Bremner | 44 | 108 | 50 | 206 | 95 | 12 | 373 | |
| Arnt‐Ove Hovden | 28 | 176 | 23 | 186 | 48 | 19 | 317 |
All Works
Loading papers...